FinancialsNonlife Insurance
  • Price (EUR)31.68
  • Today's Change0.50 / 1.60%
  • Shares traded498.12k
  • 1 Year change-16.98%
  • Beta--
Data delayed at least 15 minutes, as of Aug 16 2019 16:35 BST.
More ▼

Events & Activity

  • ASRNL:AEX price reached a new 52-week low of 30.67 at 13:36 BST
  • ASRNL:AEX price reached a new 52-week low of 30.97 at 14:49 BST
  • ASRNL:AEX price reached a new 52-week low of 31.26 at 10:00 BST
  • ASRNL:AEX price moved over -1.05% to 31.08

Key statistics

On Friday, ASR Nederland NV (ASRNL:AEX) closed at 31.68, 3.36% above its 52-week low of 30.65, set on Aug 15, 2019.
52-week range
30.65Aug 15 201943.02Oct 05 2018
Markit short selling activity
Previous close31.18
Average volume486.96k
Shares outstanding141.00m
Free float141.00m
P/E (TTM)7.54
Market cap4.47bn EUR
EPS (TTM)4.20
Annual div (ADY)1.74
Annual div yield (ADY)5.49%
Div ex-dateMay 24 2019
Div pay-dateMay 29 2019
Data delayed at least 15 minutes, as of Aug 16 2019 16:35 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.